The effects of bread containing Portulaca Oleracea on lipid profile and blood sugar in patients with type 2 diabetes.

Phase 3

• Conditions: Diabetes.; Type 2 diabetes mellitus

• Registration Number: IRCT20110309006010N1
• Lead Sponsor: Azad University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 April 2020

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Age range between 30-64 years old,
Body Mass Index(BMI), range between 19 and 35 kg per m2,
Diabetic patients referring to diabetes mellitus (known as diabetes mellitus and clinician)
Fasting blood glucose = 125mg / dl.

Exclusion Criteria

Patients receiving insulin therapy;
Patients with cardiovascular, renal, hepatic, hematological, hypothyroidism and convulsion diseases;
Patients with a history of gallstones or gallbladder surgery;
Patients under estrogen, steroid, beta-blocker and thiazide therapy;
Women planning for pregnancy; pregnant women; breast-feeding women.
The use of E and C supplements of omega 3 at least 6 months before sampling,
Smoking and narcotics as well as those who have not been used during two weeks of training,

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Fasting Blood Sugar. Timepoint: At the beginning of the study, the end of the second and fourth week. Method of measurement: Blood glucose level will be determined in laboratory by commercial standard kit.;Triglyceride. Timepoint: At the beginning of the study, the end of the second and eight week. Method of measurement: Blood triglyceride level will be determined in laboratory by commercial standard kit.;(HDL) High-density lipoprotein. Timepoint: At the beginning of the study, the end of the second and eighth week. Method of measurement: Blood HDL level will be determined in laboratory by commercial standard kit.;Low-density lipoprotein (LDL). Timepoint: At the beginning of the study, the end of the second and fourth week. Method of measurement: Blood LDL level will be determined in laboratory by commercial standard kit.

Secondary Outcome Measures

Name	Time	Method
Diastolic blood pressure. Timepoint: At the beginning of the study, the end of the second and eighth week. Method of measurement: Mercurial sphygmomanometer.;Liver Enzymes (Alanine Aminotransferase,Gamma-Glutamyl Transferase, Aspartate Amino Transferase) (AST, ALT, GGT). Timepoint: At the beginning of the study, the end of the eighth week. Method of measurement: Pars Azmon Kit.;Weight. Timepoint: At the beginning of the study, the end of the second and eighth week. Method of measurement: Scale.;Waist circumference. Timepoint: At the beginning of the study, the end of the second and eighth week. Method of measurement: Irresistible meter.;Systolic blood pressure. Timepoint: At the beginning of the study, the end of the second and eighth week. Method of measurement: Mercurial sphygmomanometer.